268 related articles for article (PubMed ID: 27233450)
1. Tat PTD-Endostatin-RGD: A novel protein with anti-angiogenesis effect in retina via eye drops.
Li Y; Li L; Li Z; Sheng J; Zhang X; Feng D; Zhang X; Yin F; Wang A; Wang F
Biochim Biophys Acta; 2016 Oct; 1860(10):2137-47. PubMed ID: 27233450
[TBL] [Abstract][Full Text] [Related]
2. Tat PTD-endostatin: A novel anti-angiogenesis protein with ocular barrier permeability via eye-drops.
Zhang X; Li Y; Cheng Y; Tan H; Li Z; Qu Y; Mu G; Wang F
Biochim Biophys Acta; 2015 Jun; 1850(6):1140-9. PubMed ID: 25662072
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
[TBL] [Abstract][Full Text] [Related]
4. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment.
Takahashi K; Saishin Y; Saishin Y; Silva RL; Oshima Y; Oshima S; Melia M; Paszkiet B; Zerby D; Kadan MJ; Liau G; Kaleko M; Connelly S; Luo T; Campochiaro PA
FASEB J; 2003 May; 17(8):896-8. PubMed ID: 12670875
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenesis effects of endostatin in retinal neovascularization.
Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
[TBL] [Abstract][Full Text] [Related]
6. Integrin alphavbeta3 as a target for blocking HIV-1 Tat-induced endothelial cell activation in vitro and angiogenesis in vivo.
Urbinati C; Mitola S; Tanghetti E; Kumar C; Waltenberger J; Ribatti D; Presta M; Rusnati M
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2315-20. PubMed ID: 16166568
[TBL] [Abstract][Full Text] [Related]
7. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models.
Jhanji V; Liu H; Law K; Lee VY; Huang SF; Pang CP; Yam GH
Br J Ophthalmol; 2011 Sep; 95(9):1309-15. PubMed ID: 21719569
[TBL] [Abstract][Full Text] [Related]
8. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
Brankin B; Campbell M; Canning P; Gardiner TA; Stitt AW
Exp Eye Res; 2005 Jul; 81(1):22-31. PubMed ID: 15978251
[TBL] [Abstract][Full Text] [Related]
9. Effect of dual PPAR-α/γ agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy.
Joharapurkar A; Patel V; Kshirsagar S; Patel MS; Savsani H; Jain M
Eur J Pharmacol; 2021 May; 899():174032. PubMed ID: 33753107
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of vascular endothelial growth factor and integrinbeta3 by endostatin in a mouse model of retinal neovascularization.
Zhang M; Yang Y; Yan M; Zhang J
Exp Eye Res; 2006 Jan; 82(1):74-80. PubMed ID: 16198337
[TBL] [Abstract][Full Text] [Related]
11. Topical application of integrin antagonists inhibits proliferative retinopathy.
Riecke B; Chavakis E; Bretzel RG; Linn T; Preissner KT; Brownlee M; Hammes HP
Horm Metab Res; 2001 May; 33(5):307-11. PubMed ID: 11440278
[TBL] [Abstract][Full Text] [Related]
12. Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin (STZ) model of diabetic retinopathy (DR).
Rao VR; Prescott E; Shelke NB; Trivedi R; Thomas P; Struble C; Gadek T; O'Neill CA; Kompella UB
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5198-204. PubMed ID: 20445119
[TBL] [Abstract][Full Text] [Related]
13. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
Campbell M; Collery R; McEvoy A; Gardiner TA; Stitt AW; Brankin B
Curr Eye Res; 2006 Dec; 31(12):1033-45. PubMed ID: 17169842
[TBL] [Abstract][Full Text] [Related]
14. Efficiency co-delivery of ellagic acid and oxygen by a non-invasive liposome for ameliorating diabetic retinopathy.
Li Z; Yu H; Liu C; Wang C; Zeng X; Yan J; Sun Y
Int J Pharm; 2023 Jun; 641():122987. PubMed ID: 37207860
[TBL] [Abstract][Full Text] [Related]
15. [Effects of propranolol on oxygen-induced retinal neovascularization in mouse].
Huang X; Wang Y; Yang G; Yang Z; Zhang J
Zhonghua Er Ke Za Zhi; 2016 Feb; 54(2):131-6. PubMed ID: 26875464
[TBL] [Abstract][Full Text] [Related]
16. RhoB antibody alters retinal vascularization in models of murine retinopathy.
Almonte-Baldonado R; Bravo-Nuevo A; Gerald D; Benjamin LE; Prendergast GC; Laury-Kleintop LD
J Cell Biochem; 2019 Jun; 120(6):9381-9391. PubMed ID: 30536763
[TBL] [Abstract][Full Text] [Related]
17. In vitro and ex vivo retina angiogenesis assays.
Rezzola S; Belleri M; Gariano G; Ribatti D; Costagliola C; Semeraro F; Presta M
Angiogenesis; 2014 Jul; 17(3):429-42. PubMed ID: 24121991
[TBL] [Abstract][Full Text] [Related]
18. A Novel Small Peptide H-KI20 Inhibits Retinal Neovascularization Through the JNK/ATF2 Signaling Pathway.
Wang R; Xu Y; Niu C; Gao X; Xu X
Invest Ophthalmol Vis Sci; 2021 Jan; 62(1):16. PubMed ID: 33439229
[TBL] [Abstract][Full Text] [Related]
19. Effects of endostatin-vascular endothelial growth inhibitor chimeric recombinant adenoviruses on antiangiogenesis.
Pan X; Wang Y; Zhang M; Pan W; Qi ZT; Cao GW
World J Gastroenterol; 2004 May; 10(10):1409-14. PubMed ID: 15133844
[TBL] [Abstract][Full Text] [Related]
20. Imidazole-based alkaloid derivative LCB54-0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization.
Kim BH; Lee J; Choi JS; Park DY; Song HY; Park TK; Cho CH; Ye SK; Joo CK; Koh GY; Kim TY
Br J Pharmacol; 2015 Aug; 172(15):3875-89. PubMed ID: 25917462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
